Watson's World
By Jesse Reynolds
| 10. 24. 2007
Nobel Prize season has come to an awkward end. Once a day during last week, we heard announcements of the winners in the six fields, including a high-profile award to Al Gore. The recipients will forever be honored to include the word "laureate" in their biographies.
But a few days later, the most prominent Nobel scientist winning scientist deeply marred his reputation. James Watson, who in 1962 won the prize for his elucidation of DNA's structure, unequivocally stated in an interview with the United Kingdom's Sunday Times that black people are less intelligent than whites. Speaking on development programs in Africa, Watson lamented that "all our social policies are based on the fact that their intelligence is the same as ours - whereas all the testing says not really… [P]eople who have to deal with black employees find [equality] is not true."
It may be tempting to dismiss this stunning utterance as the sloppy, irrelevant ramblings of a once-great scientist who is well past his prime. But Watson is a remarkably influential figure who has consistently reduced behavior to biology...
Related Articles
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...